172 related articles for article (PubMed ID: 20551262)
1. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
Jakobiec FA; Werdich X
Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
5. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor).
Mulay K; White VA; Shah SJ; Honavar SG
Can J Ophthalmol; 2014 Aug; 49(4):326-32. PubMed ID: 25103648
[TBL] [Abstract][Full Text] [Related]
6. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
7. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
8. Histopathological review of sebaceous carcinoma of the eyelid.
Pereira PR; Odashiro AN; Rodrigues-Reyes AA; Correa ZM; de Souza Filho JP; Burnier MN
J Cutan Pathol; 2005 Aug; 32(7):496-501. PubMed ID: 16008694
[TBL] [Abstract][Full Text] [Related]
9. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
[TBL] [Abstract][Full Text] [Related]
10. [A study on the expression of p16 protein and bcl-2 protein in cutaneous eyelid tumors].
Niu Y; Liu F; Meng X; Wang H; Lin H
Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):259-62, 15. PubMed ID: 11853608
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
Ansai S; Arase S; Kawana S; Kimura T
J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
[TBL] [Abstract][Full Text] [Related]
12. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
13. [A study on expressions of P53 protein and proliferating cell nuclear antigen in malignant eyelid tumors].
Niu Y; Wang H; Ji J; Lin H; Zhang A
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):36-9, 5. PubMed ID: 11835772
[TBL] [Abstract][Full Text] [Related]
14. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
Yu L; Galan A; McNiff JM
J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
[TBL] [Abstract][Full Text] [Related]
15. [Pathology in the diagnosis and treatment of palpebral tumors].
Pluot M; Ducasse A
J Fr Ophtalmol; 2003 Jan; 26(1):77-83. PubMed ID: 12610415
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
Sinard JH
Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of Ki-67 and PCNA expression in conjunctival and eyelid tumours.
Reszeć J; Kańczuga-Koda L; Sulkowska M; Koda M; Cylwik J; Barwijuk-Machała M; Sulkowski S
Folia Morphol (Warsz); 2004 Feb; 63(1):95-8. PubMed ID: 15039910
[TBL] [Abstract][Full Text] [Related]
18. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
Heyl J; Mehregan D
J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
Arits AH; Van Marion AM; Lohman BG; Thissen MR; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Eur J Dermatol; 2011; 21(6):870-3. PubMed ID: 21865121
[TBL] [Abstract][Full Text] [Related]
20. [Palpebral tumors: clinical and diagnostic considerations].
Lasudry J
J Fr Ophtalmol; 2003 Jan; 26(1):70-6. PubMed ID: 12610414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]